EVI1 overexpression is a poor prognostic factor in pediatric patients with mixed lineage leukemia-AF9 rearranged acute myeloid leukemia

Affiliations

• ¹ Department of Human Health Sciences, Kyoto University, Japan.
• ² Department of Pediatrics, Tokyo Medical and Dental University (TMDU), Japan.
• ³ Department of Nutritional Science, Aichi Gakuin University, Nisshin, Japan.
• ⁴ Clinical Research Center, National Hospital Organization Nagoya Medical Center, Japan.
• ⁵ Epidemiology and Clinical Research Center for Children's Cancer, National Center for Child Health and Development, Tokyo, Japan.
• ⁶ Department of Pediatrics, Kyoto University, Japan.
• ⁷ Department of Pediatrics, National Hospital Organization Fukuoka-Higashi Medical Center, Koga, Japan.
• ⁸ Department of Pediatrics, St. Marianna University School of Medicine, Kawasaki, Japan.
• ⁹ Department of Pediatrics, Shiga University of Medical Science, Otsu, Japan.
• ¹⁰ Department of Pediatrics, National Hospital Organization Osaka National Hospital, Japan.
• ¹¹ Department of Molecular Diagnostics and Therapeutics, Kyoto Prefectural University of Medicine, Japan.
• ¹² Department of Pediatrics, Gunma University Graduate School of Medicine, Maebashi, Japan.
• ¹³ Department of Hematology and Oncology, Gunma Children's Medical Center, Shibukawa, Japan.
• ¹⁴ Department of Pediatrics, National Hospital Organization Nagoya Medical Center, Japan.
• ¹⁵ Department of Pediatrics, Okayama University Hospitaland, Japan.
• ¹⁶ Department of Pharmacoepidemiology, Kyoto University, Japan.
• ¹⁷ Department of Human Health Sciences, Kyoto University, Japan adachiso@kuhp.kyoto-u.ac.jp.